Clinical Trials Logo

Safety Issues clinical trials

View clinical trials related to Safety Issues.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06460987 Completed - Safety Issues Clinical Trials

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Start date: December 1, 2022
Phase:
Study type: Observational

IgA nephropathy accounts for about 45 per cent of primary glomerular diseases in China and about 26 per cent of renal biopsies in patients with chronic failure.According to current guideline recommendations, there are limited indications for non-steroidal MRAs. Therefore clinical studies to explore the range of clinical indications for fenetyllone are warranted.

NCT ID: NCT06394505 Completed - Safety Issues Clinical Trials

Operating Room Nurses' Risks and Perceptions of Safety Climate

Start date: March 1, 2024
Phase:
Study type: Observational

One of the leading elements in providing safe healthcare is to maintain employee health and safety. Hazards in the working environments of healthcare professionals threaten employee safety and cause errors in patient care. In this case, healthcare professionals working in a safe environment means that patients receive service in a safe environment. Safety climate is the perception of employees of the policies, procedures and practices that exist to ensure safety in the workplace and is an important element for the formation of a safety culture in the workplace. There are many factors that determine the perception of safety climate. These factors can be listed as the type and size of the organization, the occupational risks that employees are exposed to at work, the way occupational safety is managed, the gender, seniority of employees, and their position in the organization.

NCT ID: NCT06291948 Completed - Pharmacokinetics Clinical Trials

A Clinical Study With Adalimumab Biosimilar

Start date: August 1, 2022
Phase: Phase 1
Study type: Interventional

The study aims to evaluate the pharmacokinetic profile, safety profile, and immunogenic potential of adalimumab of a new citrate-free formulation of adalimumab (Adalimumab Richmond) [Test Product] vs. Humira® AC Pen [Reference Product]

NCT ID: NCT06117800 Completed - Safety Issues Clinical Trials

Effect of Evidence Based Teamwork System on Patient Safety Culture

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of evidence-based teamwork system on patient safety culture among newly graduate nurses at Main Mansoura University Hospital

NCT ID: NCT06053853 Completed - Safety Issues Clinical Trials

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Start date: January 31, 2023
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate the safety profile of Diphtheria Antitoxin

NCT ID: NCT06006078 Completed - Safety Issues Clinical Trials

Aersosolization During Upper Endoscopy

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Given the current Covid-19 pandemic alongside the lack of evidence on aerosolization during upper endoscopy the investigators are conducting a randomized controlled trial seeking to assess both the level of aerosolization that occurs during these procedures along with determining if utilization of an endoscopic patient face-masks reduces the level of aerosolized particles. The protocol includes the use of a commercially available particle counter the investigators are employing for the measurement of aerosols before, during, and after anesthesia assisted upper endoscopic procedures. The investigators are recruiting patients undergoing these procedures with a target of 30 patients undergoing endoscopy without a facemask and 30 patients undergoing endoscopy with one.

NCT ID: NCT05973812 Completed - Safety Issues Clinical Trials

Safety of Bifidobacterium Breve PS1 for Infants

Start date: December 12, 2012
Phase: N/A
Study type: Interventional

The objective of this work was the characterization of the probiotic potential of Bifidobacterium breve PS1, a strain originally isolated from human milk. Subsequently, its safety and tolerance were evaluated in a trial including healthy, formula-fed 3-months-old infants. A total of 187 infants were randomized into two groups: probiotic group (PG) and control group (CG). Both groups received the same infant formula but, in the case of the PG, it was supplemented with the strain. A total of 160 infants (80 per group) completed the three months of intervention.

NCT ID: NCT05901012 Completed - Healthy Volunteers Clinical Trials

Safety and Tolerability of DMT in Healthy Adults

Start date: April 26, 2023
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the acute and subacute effects of an inhaled N, N-Dimethyltryptamine (DMT) in healthy individuals.

NCT ID: NCT05798000 Completed - Safety Issues Clinical Trials

Effect of WHO Surgical Safety Checklist and Anesthesia Equipment Checklist on Patients Outcomes in Low-resource Settings.

Start date: February 1, 2022
Phase:
Study type: Observational

The study to investigate the effectiveness and the current perception of safety checklists in Ukrainian hospitals.

NCT ID: NCT05795192 Completed - Pharmacokinetics Clinical Trials

SB17170 Phase1 Trial in Healthy Volunteer

Start date: May 24, 2023
Phase: Phase 1
Study type: Interventional

This clinical trial aims to learn about the safety, tolerability, and pharmacokinetic properties of SB17170 and its active metabolite SB1703 in single and multiple oral administration in healthy adults. The main questions it aims to answer are the safety, tolerability, and PK characteristics of SB17170 in healthy adults.